#WorldDiabetesDay is THIS FRIDAY, November 14th!
If you're planning to dine out this week, please keep these two businesses in mind. They are partnering with the Indiana Chapter of T1International to raise funds.
#WorldDiabetesDay is THIS FRIDAY, November 14th!
If you're planning to dine out this week, please keep these two businesses in mind. They are partnering with the Indiana Chapter of T1International to raise funds.
For the diabetes community:
The California insulin is long acting insulin glargine, which is biosimiliar to Lantus.
A fast acting insulin similar to Novoloh is in the works.
Their, saved you having to look it up.
During the "CT Public Pharma Conversation", held on 7 October 2024 at Yale Law School and organised by the Connecticut chapter of the #Insulin4All campaign and T1International, Dana Brown, Health and Economy Fellow at The Democracy Collaborative, made the case for establishing a Public Pharma.
๐Watch the full event: https://www.youtube.com/watch?v=6UBVXByANKE
During the "CT Public Pharma Conversation", held on 7 October 2024 at Yale Law School and organised by the Connecticut chapter of the #Insulin4All campaign and T1International, Dana Brown, Health and Economy Fellow at The Democracy Collaborative, advocated for Public Pharma as a way to treat medicine as a public service rather than a commodity.
๐Watch the full event: https://www.youtube.com/watch?v=6UBVXByANKE
During the "CT Public Pharma Conversation", held on 7 October 2024 at Yale Law School and organised by the Connecticut chapter of the #Insulin4All campaign and T1International, Arden Parrish, Pre-Medical Student at Yale University and Connecticut Insulin4All Chapter Lead, shared their personal account as someone living with type 1 diabetes and an advocate for fair access to insulin.
๐Watch the full event: https://www.youtube.com/watch?v=6UBVXByANKE
With the amount of money I spend on #T1D every year I could afford to buy 12+ gaming systems.
And that doesnโt include the 10k I spent on my broken thumb due to a low. ๐
Bernie at the Senate hearing on insulin and pharmaceutical prices
Drug manufacturer Eli Lilly announced that it will cap the monthly out-of-pocket cost to patients of a prescription for insulin at $35 a month. #insulin4all #insulin